Академический Документы
Профессиональный Документы
Культура Документы
Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at http://www.jstor.org/page/
info/about/policies/terms.jsp
JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content
in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms of scholarship.
For more information about JSTOR, please contact support@jstor.org.
American Association of Avian Pathologists and Allen Press are collaborating with JSTOR to digitize, preserve and extend
access to Avian Diseases.
http://www.jstor.org
This content downloaded from 198.91.37.2 on Sun, 20 Dec 2015 23:46:54 UTC
All use subject to JSTOR Terms and Conditions
AVIANDISEASES39:528-531, 1995
528
This content downloaded from 198.91.37.2 on Sun, 20 Dec 2015 23:46:54 UTC
All use subject to JSTOR Terms and Conditions
ILTVin QT-35 cells 529
This content downloaded from 198.91.37.2 on Sun, 20 Dec 2015 23:46:54 UTC
All use subject to JSTOR Terms and Conditions
530 W. M. Schnitzlein and D. N. Tripathy
Cell line Source Yield (PFU)8 Cell line FrozenB Titer (PFU/ml)c
QT-35 Medium 1.0 x 10' QT-35 - 4.3 x 103
Detached cells 5.6 x 102 + 7.8 x 10'
Adherentcells 7.3 x 103 IQ1A - 6.2 x 103
LMH Medium 4.9 x 102 + 5.7 x 101
Detached cells 9.0 x 102 LMH - 4.3 x 103
Adherentcells 4.6 x 103 + 6.8 x 103
AYieldswere determined 3 days after the 6th sub- ATiterswere determined 3 days after the 12th sub-
culturing of ILTV-infectedQT-35 cells onto an un- culturing of ILTV-infectedQT-35 cells onto an un-
infected monolayerof approximately2 x 106 cells. infected monolayerof approximately4 x 106 cells.
BYields were normalized to represent the total BWhenrequired, ILTV-infectedQT-35 cells were
amountof infectious virus present in each fractionof disrupted by placement at -80 C.
the subculture, as determined on the two cell lines. CTitersrepresent infectious virus present in adher-
ent cells, which had been resuspendedin 2 ml growth
medium following dissociation.
This content downloaded from 198.91.37.2 on Sun, 20 Dec 2015 23:46:54 UTC
All use subject to JSTOR Terms and Conditions
ILTV in QT-35 cells 531
events must occur between QT-35cells and ex- 5. Moscovi, C., G. M. Moscovi, and H. Jimenez.
tracellularLMHcell-adapted ILTV,since intra- Continuous tissue culture cell lines derived from
cellular infection can be transferredonly to ho- chemically induced tumors of Japanese quail. Cell
11:95-103. 1977.
mologous LMHcells and not to the heterolo- 6. Schnitzlein, W. M., J. Radzevicius, and D. N. Tri-
gous quail cells (unpublished data). pathy. Propagation of infectious laryngotracheitis vi-
rus in an avian liver cell line. Avian Dis. 38:211-217.
REFERENCES 1994.
7. Scholz, E., E. Welniaj, T. Nyholm, and P. Guo.
1. Condreay,L. D., C. E. Aldrich, L. Coates, W. S. An avian hepatoma cell line for the cultivation of
Mason,and T.-T.Wu. Efficientduck hepatitis B virus infectious laryngotracheitis virus and for the expres-
production by an avian liver tumor cell line. J. Virol. sion of foreign genes with a mammalian promoter. J.
64:3249-3258. 1990. Virol. Methods 43:273-286. 1993.
2. Cowen, B. S., and M. 0. Braune. The propaga- 8. Seddon, H. R., and L. Hart. Infectivity experi-
tion of avianviruses in a continuous cell line (QT35) ments with the virus of laryngotracheitis of fowls. Aust.
of Japanese quail origin. AvianDis. 32:282-297. 1988. Vet. J. 12:13-16. 1936.
3. Hanson, L. E., and T. J. Bagust. Laryngotrache-
itis. In: Diseases of poultry, 9th ed. B. W. Calnek,H.
J. Barnes,C. W. Beard,W. M. Reid, and H. W. Yoder,
Jr., eds. Iowa State UniversityPress,Ames, Iowa. pp.
485-495. 1991. ACKNOWLEDGMENTS
4. Kawaguchi,T., K. Nomura,Y. Hirayama,and T.
Kitagawa. Establishment and characterizationof a This work was supported by USDA grant AG-87-
chicken hepato-cellular carcinoma cell line, LMH. CRCR-2-3102, RRF VRNC 116-0332, and a grant from
CancerRes. 47:4460-4464. 1987. Schering-Plough Animal Health Corp.
This content downloaded from 198.91.37.2 on Sun, 20 Dec 2015 23:46:54 UTC
All use subject to JSTOR Terms and Conditions